This week, Fluorobiotech’s COO, Ross Rayne Vermeulen, attended a landmark event in Johannesburg celebrating the launch of clinical trials for South Africa’s first domestically developed cholera vaccine, a major achievement led by Biovac. The ceremony marked the start of Phase I safety trials, representing a pivotal advancement not only for...